FDA Panel Success Puts ThermoCool First In Line For AF Ablation Indication
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/Biosense Webster's Navistar ThermoCool saline irrigated radio-frequency ablation catheterhas the inside track to become the first ablation catheter with an FDA-approved indication for atrial fibrillation following a unanimous recommendation from the agency's Circulatory System Devices Panel
You may also be interested in...
Bayesian Gets A Boost With Guidance, But Technique Still Not For Everyone
The complex calculations of Bayesian statistics are not likely to become standard for FDA device submissions anytime soon, but they could help streamline clinical trials in many more instances, CDRH's top statistics official says
Bayesian Gets A Boost With Guidance, But Technique Still Not For Everyone
The complex calculations of Bayesian statistics are not likely to become standard for FDA device submissions anytime soon, but they could help streamline clinical trials in many more instances, CDRH's top statistics official says
FDA Approves J&J’s Navistar ThermoCool For Atrial Fibrillation Ablation
With PMA approval Feb. 6, Johnson & Johnson/Biosense Webster's NaviStar ThermoCool and EZ Steer ThermoCool Navigational became the first cardiac ablation catheters approved by FDA specifically for treatment of atrial fibrillation